Finland· FI-REL-REL2295
Gevilon
A gemfibrozil product containing gemfibrozil, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Gemfibrozil is registered in 12 of 19 countries.
Countries holding a registration under ATC C10AB04 (gemfibrozil), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Gemfibrozil · ATC C10AB04
12 / 19 countries
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of gemfibrozil costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gemfibrozil · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- FR France$0.50
- IT Italy$0.42
The record
At a glance
Fimea (Finland)- Active substance
- Gemfibrozil
- Manufacturer
- Orion Corporation Orion Pharma
- Country
- Finland (FI)
- ATC code
- C10AB04
- ATC class
- Gemfibrozil
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
165 interactions on record for gemfibrozil.
Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gemfibrozil · interactions on record
165 records
- 19 severe
- 57 moderate
- 2 minor
- 85 info
Most severe, free to view
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
- PioglitazoneA10BG03severe
- RepaglinideA10BX02severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gemfibrozil in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGemfibrozil 300mg capsulesA A H Pharmaceuticals Ltd
- IrelandLopid 300 mg capsules, hardPfizer Healthcare Ireland Unlimited Company
- NetherlandsLopid 300 mg, harde capsulesPfizer B.V.
- NorwayLopidPfizer
- United StatesGemfibrozilREMEDYREPACK INC.
- SpainGEMFIBROZILO STADA 600 mg COMPRIMIDOS EFGLaboratorio Stada S.L.
- ItalyGEMFIBROZIL DOC GENERICIDOC GENERICI S.R.L.
- CanadaTEVA-GEMFIBROZILTEVA CANADA LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Gevilon
- Cyprus · Ipolipid, Lipofor
- Denmark · Lopid
- Spain · Gemfibrozilo Stada, Gemfibrozilo Tarbis
- France · Lipur
- United Kingdom (Northern Ireland) · Gemfibrozil Tillomed Laboratories, Lopid
- Greece · Fibrolip, Gemlipid
- Ireland · Lopid
- Iceland · Lopid
- Italy · Gemfibrozil Doc Generici, Gemfibrozil Eg
- Netherlands · Gemfibrozil Aurobindo, Lopid
- Portugal · Gemfibrozil Generis, Lopid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/47fee457-87e5-4c96-8e8c-37cfe1cbd215 GET /v1/drugs/47fee457-87e5-4c96-8e8c-37cfe1cbd215?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1.2",
"form": "kapseli, kova",
"route": null,
"ddd_unit": "g",
"strength": "300 mg",
"atc_label": "gemfibrotsiili",
"ma_number": "9703",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL2295",
"authorised_at": "1988-06-22"
}See everything about gemfibrozil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.